Zacks Investment Research on MSN
UiPath's AI automation model is driving platform-level efficiency
UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...
"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...
PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...
PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.
UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...
UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation software company, today announced its newest platform features that help customers gain real value by transforming ...
NEW YORK--(BUSINESS WIRE)-- UiPath (PATH), a global leader in agentic automation, announced today the launch of the UiPath Conversational Agent with voice interaction enabled by Google’s Gemini models ...
UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...
C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative ...
It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results